News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dybbs Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Dybbs Michael (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
| 06/09/2023 |
4
| Dybbs Michael (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Dybbs Michael (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 10,700 options to buy
@ $18, valued at
$192.6k
|
|
| 07/09/2020 |
3
| Dybbs Michael (Director) has filed a Form 3 on Nkarta, Inc. |
| 06/08/2020 |
4
| Dybbs Michael (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 12,000 options to buy
@ $9.83, valued at
$118k
|
|
| 06/19/2019 |
4
| Dybbs Michael (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 11,610 options to buy
@ $11.12, valued at
$129.1k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/07/2017 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 32,069 options to buy
@ $7.08, valued at
$227k
Disposed/sold 17,000 options to buy
@ $1.15, valued at
$19.6k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2016 |
4
| Dybbs Michael (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
|
|